Skip to content

Diagnosis and Treatment of Patients With Cystic Fibrosis

Diagnosis and Treatment of Patients With Cystic Fibrosis

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00001223
Enrollment
79
Registered
1999-11-04
Start date
1988-01-01
Completion date
2026-01-30
Last updated
2026-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis, Diabetes, Liver Disease or Abnormalities, Pancreatic Insufficiency (Exocrine and Endocrine)

Keywords

Cystic Fibrosis, Pancreatic Insufficiency, Bronchiectasis, Liver Disease, Natural History

Brief summary

This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expand knowledge of the natural history, clinical manifestations (phenotypes) and the genetic variants (genotypes) of cystic fibrosis.

Detailed description

This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expand knowledge of the natural history, clinical manifestations (phenotypes) and the genetic variants (genotypes) of cystic fibrosis.

Interventions

None listed

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Lead SponsorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
4 Years to 120 Years
Healthy volunteers
No

Inclusion criteria

* INCLUSION CRITERIA * Patients with known or suspected CF and family members of patients with CF. * \>=4 years of age

Exclusion criteria

-Concomitant medical, psychiatric or other problems which might complicate interpretation of studies of CF, or for which we are unable to provide adequate care.

Design outcomes

Primary

MeasureTime frameDescription
To develop a database and collection of samples obtained from patients with CF during their clinical care to allow for future researchend of studyTo develop a collection of samples and a database from patients with cystic fibrosis to be used in future research.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORChristopher Koh, M.D.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026